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Abstract
The small GTPase RhoA plays a crucial role in the regulation of neuronal signalling to
generate behaviour. In the developing nervous system RhoA is known to regulate the actin
cytoskeleton, however the effectors of RhoA-signalling in adult neurons remain largely
unidentified. We have previously shown that activation of the RhoA ortholog (RHO-1) in
C. elegans cholinergic motor neurons triggers hyperactivity of these neurons and loopy loco-
motion with exaggerated body bends. This is achieved in part through increased diacylgly-
cerol (DAG) levels and the recruitment of the synaptic vesicle protein UNC-13 to synaptic
release sites, however other pathways remain to be identified. Dopamine, which is nega-
tively regulated by the dopamine re-uptake transporter (DAT), has a central role in modulat-
ing locomotion in both humans and C. elegans. In this study we identify a new pathway in
which RHO-1 regulates locomotory behaviour by repressing dopamine signalling, via DAT-
1, linking these two pathways together. We observed an upregulation of dat-1 expression
when RHO-1 is activated and show that loss of DAT-1 inhibits the loopy locomotion pheno-
type caused by RHO-1 activation. Reducing dopamine signalling in dat-1 mutants through
mutations in genes involved in dopamine synthesis or in the dopamine receptor DOP-1
restores the ability of RHO-1 to trigger loopy locomotion in dat-1 mutants. Taken together,
we show that negative regulation of dopamine signalling via DAT-1 is necessary for the neu-
ronal RHO-1 pathway to regulate locomotion.
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Introduction
The small Rho GTPase RhoA is a well-characterized regulator of the actin cytoskeleton [1,2].
In the nervous system RhoA acts on actin dynamics to regulate neuronal polarity [3], axon
outgrowth [4], dendritic branching and synaptic connectivity [5]. RhoA has more recently
been shown to play a role in neuronal activity by regulating endocytotic events [6], synaptic
plasticity [7], and by enhancing learning and memory in adult mice [8]. Malfunctions in
RhoA-signalling pathways are related to mental retardation phenotypes, which can be restored
in the adult implicating new treatments for these disorders [9,10]. In C. elegans the single Rho-
ortholog (RHO-1) is expressed throughout the nervous system [11] and is required for cell
migration, cell shape regulation, and neurite outgrowth [12–14]. Our previous work together
with the work of others demonstrates that RHO-1 acts via multiple pathways to regulate loco-
motion in adult animals [15–19]. Inhibition of endogenous RHO-1 signalling results in lethar-
gic locomotion with shallow body bends [16,18,19], whilst activation of RHO-1 signalling
triggers a neuronal hyperactivity and loopy locomotion associated with increased acetylcholine
(ACh) release and exaggerated body bends [18]. RHO-1 regulates neuronal function down-
stream of a network of G-protein signalling pathways in cholinergic neurons [15–17], of
which at least two regulate locomotion: RHO-1 regulates locomotion downstream of Gq via
the activation of the NALCN ortholog NCA cation channels [16] and downstream of G12
through the regulation of diacylglycerol kinase (DGK-1) and the recruitment of the synaptic
vesicle protein UNC-13 to release sites [18]. However, the evidence suggests that there are
unidentified down stream targets of RHO-1 that are required for the regulation of locomotion
[18].
Dopamine signalling controls mood, reward, motor control, and learning in humans [20].
It is negatively regulated by the dopamine transporter (DAT), which removes dopamine from
the extracellular space reducing the concentration and spread of dopamine [21]. DAT is the
target of legal (modafinil and Ritalin) and illegal (cocaine and amphetamines) psychostimu-
lants [22], implicating its importance in regulating dopamine signalling. Polymorphisms in
human DAT have been related to mental health disorders such as ADHD, drug abuse, bipolar
disorder, Tourette syndrome, and autism [23–25]. Loss of function mutations of DAT have
been associated with infantile parkinsonism-dystonia [26] and mutations in genes encoding
DAT-associated proteins such as α-synuclein and Parkin are associated with inherited forms
of Parkinson’s disease [27,28]. Pharmacological interventions targeting DATs through cocaine
or amphetamine application result in the modulation of DAT function and lead to severe
behavioural effects [29–31]. Therefore, understanding how DAT function, trafficking and
gene expression are regulated has significance both biologically and sociologically. Many of
these underlying mechanism have been studied [22,24,32–34], highlighting DAT as an integral
component of the dopamine signalling pathway, which regulates behaviour.
Dopamine, which is negatively regulated by DAT, has a central role in modulating locomo-
tion in both humans and C. elegans [35–37]. In C. elegans, dopamine signalling mutants fail to
switch from swimming to crawling locomotion when they move from a liquid to a solid sur-
face, they also fail to slow down when they encounter a bacterial lawn [37,38]. In contrast,
increased dopamine signalling slows locomotion accompanied by shallow body bends [39–
41]. Dopamine via DOP-3 receptors negatively modulates the activity of NCA channels to
reduce locomotion whereas RHO-1 signalling activates them [16,17]. Thus, the dopamine and
RHO-1 pathways have opposite effects on locomotion. The C. elegans DAT-1 is conserved
with human DAT, shares trafficking mechanisms and has similar kinetics of dopamine reup-
take and sensitivity to drugs [42–44]. Activation of RhoA has been shown to regulate DAT-
internalization in mouse midbrain slices [31], and DAT-surface availability in C. elegans [43]
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cell autonomously linking RhoA to DAT function. In this study, we show that dat-1 is required
for RHO-1 to modulate locomotion in vivo. We propose a model whereby enhanced RHO-1
signalling in cholinergic motor neurons leads to a cell non-autonomous transcriptional upre-
gulation of dat-1 in dopaminergic neurons. This decreases the dopaminergic signalling that
normally acts to reduce locomotion and enables RHO-1 signalling to drive locomotion. Our
data suggest that the neuronal RHO-1 pathway regulates dat-1 gene expression to fine-tune
locomotory behaviour.
Results
RHO-1 signalling regulates locomotion
Previously we have shown that RHO-1 signalling in adult cholinergic neurons is required for
normal locomotion [18,45]. Reducing RHO-1 signalling, by expressing the RHO-1 inhibitor C3
transferase in adult cholinergic neurons or using the Rho GEF mutant unc-73(ce362), results in
lethargic locomotion characterized by flat, shallow body bends [18,19] while expressing the con-
stitutively active RHO-1 (RHO-1 (G14V)) mutant from the unc-17 promoter in cholinergic
neurons (nRHO-1) drives hyperactive locomotion, best characterized by exaggerated loopy
body bends (Fig 1A, S2 Movie) [18]. For a more detailed analysis of the nRHO-1 mediated
loopy locomotion behaviour we quantified body curvature using the Worm Tracker 2.0.4 sys-
tem and the Worm Analysis Tool Box version 3 [46]. The degree of curvature of hyperactive
loopy nRHO-1 animals compared to wild type animals was significantly increased at each of
the five equally spaced points along the body (all p< = 0.0001) (Fig 1B and 1C, S1 and S2 Mov-
ies), indicating that nRHO-1 increases curvature along the entire body (Fig 1C). For clarity
one point on the worm, mean hip (point 4), was chosen to represent alterations in curvature on
subsequent strains (See Material and Methods). Given that nRHO-1 animals have altered body
curvature we employed a second locomotion assay, the dispersal assay, to determine the effect
of this change on the animal’s ability to cover distance over time. Animals are placed in the cen-
tre of a large NGM plate that has a narrow ring of food around the outside edge. The number of
animals that reach the ring of food, at given time points, are scored as a percentage of the total
number of animals on the plate [47] (Fig 1D). We observed that 95.2% ±0.8 of the wild type ani-
mals reached the food after 60 minutes while within this time only 0.5% ±0.5 of nRHO-1 ani-
mals did so (p< = 0.0001) (Fig 1E). Approximately 50% of the nRHO-1 animals reached the
food when plates were left overnight (data not shown) suggesting that despite being loopy
nRHO-1 hyperactive animals are still able to direct their locomotion to a certain extent,
although at a far slower rate when compared to wild type animals.
dat-1 mutations suppress nRHO-1 mediated changes in locomotion
Our previous work together with the recent work of others [16,18] demonstrates that RHO-1
acts via multiple pathways to regulate locomotion. One of these pathways involves RHO-1 neg-
atively regulating diacylglycerol kinase (DGK-1) to increase diacylglycerol (DAG) levels at
release sites resulting in the recruitment of UNC-13. However, other DGK-1 independent
pathways acting downstream of RHO-1 remain to be identified [18]. To identify these other
components of neuronal RHO-1 signalling pathways we performed a forward genetic screen
for mutations that suppressed nRHO-1 mediated increases in curvature. The original sup-
pressor screen strain had both versions of active RHO-1, nRHO-1 and heat shock hs::RHO-
1, only alleles supressing both were chosen to be suppressor mutants. One mutant, nz99,
showed a significant decrease in curvature from 33.1˚ ±0.5 in nRHO-1 to 27.1˚ ±0.8 in
nRHO-1;nz99 animals (p< = 0.0001) (Fig 2B). Whole genome sequencing of the nRHO-1;
nz99 strain identified 42 mutations predicted to alter protein coding (S1 Table). Among these
RHO-1 requires DAT-1 to control C. elegans locomotion
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Fig 1. nRHO-1 expression alters locomotion phenotypes. a Representative images of control strains (wild type, dat-1(ok157)) and different nRHO-1 animals
showing characteristic body curvature and motion tracks on a culture dish (8x magnification). b Worm tracking data of body curvature at 5 body points within the
worm (as shown in c) comparing control animals (wild type) to nRHO-1 animals. Statistical comparisons were performed using one-way ANOVA and presented as
mean curvature ± SEM with Tukey’s multiple test correction. Diamonds indicate outliers. Statistical significance indicated as (P 0.001), n = 70 and 32 animals
respectively. c Schematic of a C. elegans. Reference points to measure body curvature using worm tracker terminology and indicated as red dots.d Schematic
presentation of dispersal assay as described in materials and methods. e Dispersal assay as described in materials and methods. Genotypes are color-coded as indicated
below the panel. Hash keys represent data points 1%. Data presented as the mean percentage of animals on food at indicated time points ± SEM. Statistical
comparisons were performed using two-way ANOVA with Tukey’s multiple test correction. Statistical significance indicated as (P 0.001), n = 3 experiments (~200
animals per assay).
https://doi.org/10.1371/journal.pone.0204057.g001
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Fig 2. A dat-1 mutation suppresses nRHO-1 locomotion phenotypes. a Schematic of the dat-1 gene with alleles ok157 and nz99 indicated. b Worm
tracking data of body curvature measurements of control animals (wild type, dat-1(ok157)), nRHO-1 animals, nRHO-1 suppressor strains (nRHO-
1;dat-1(nz99) and nRHO-1;dat-1(ok157)) and rescue lines. Statistical comparisons were performed using one-way ANOVA and presented as mean
hip ± SEM with Tukey’s multiple test correction. Diamonds indicate outliers. Statistical significance indicated as (P 0.001, n.s. = not significant),
n = 70, 14, 32, 19, 15, 18, and 17 animals respectively.c Dispersal assay as described in materials and methods. Genotypes are color-coded as indicated
on the right side of the panel. Hash keys represent data points 1%. Data presented as the mean percentage of animals on food at indicated time
points ± SEM. Statistical comparisons were performed using two-way ANOVA with Tukey’s multiple test correction. Statistical significance indicated
as (P 0.001, n.s. = not significant), n = 3 experiments (~200 animals per assay).d Aldicarb assay as described in materials and methods. Control
strains (wild type, dat-1(ok157)), nRHO-1 animals and nRHO-1;dat-1(ok157) double mutant assayed on 1mM Aldicarb. Genotypes are color-coded
as indicated below the panel. Data presented as mean percentage of paralyzed animals scored every 10 minutes up to 100 min ± SEM, n = 3 (>30
animals per assay).
https://doi.org/10.1371/journal.pone.0204057.g002
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only one nonsense mutation was identified, which encoded a GAG->TAG (Glu->stop)
change in the dopamine transporter DAT-1 (Fig 2A). The mutation in dat-1 was of significant
interest as changes in dopamine signalling are known to affect locomotion [48]. Therefore, we
sought to confirm whether decreasing DAT-1 could suppress nRHO-1 using a canonical dat-
1 allele, ok157 (Fig 2A). Like the suppressor mutation nz99 dat-1(ok157) significantly sup-
pressed nRHO-1-mediated increased curvature from 33.1˚ ±0.5 in nRHO-1 to 25.8˚ ±0.6 in
nRHO-1;dat-1(ok157) (p< = 0.0001) (Figs 1A and 2B, S3 Movie). This dat-1(ok157) allele,
like nz99, was also able to supress the loopy locomotion in our heat shock activated hs::RHO-
1 strain (Figure a in S1 Fig). Previously, Yemini et al reported that dat-1(ok157) animals have
alterations in a number of locomotory aspects [49]. We analysed mean curvature of the hip as
well as the other 4 body points and observed no significant difference between the dat-1
(ok157) and wild type animals (Figs 1C and 2B, Figure b in S1 Fig, S1 and S4 Movies). Simi-
larly, we observed no significant difference in the dispersal assay between dat-1(ok157) and
wild type animals (Fig 2C) indicating that dat-1(ok157) animals are able to co-ordinate their
locomotion to the same extent as wild type animals. However, the dat-1(ok157) mutation sig-
nificantly suppressed the dispersal phenotype of nRHO-1. After 4 hours 52.7% ±2.8 of the
nRHO-1;dat-1(ok157) animals reached the food compared to only 7.3% ±4.2 of nRHO-1 ani-
mals (p< = 0.0001) (Fig 2C). Approximately 100% of the nRHO-1;dat-1(ok157) animals
reached the food when plates were left overnight (data not shown). For all further experiments
we used the dat-1(ok157) allele instead of the nz99 strain, as this allele has been widely reported
in the literature, and strains in which dat-1(ok157) has been extensively backcrossed are
available.
Although dat-1(ok157) significantly suppressed the increase in curvature and failure to dis-
perse at 4 hours observed in nRHO-1 animals, it did not fully restore the nRHO-1 levels of
curvature (17.4˚ ±0.3 in wild type compared to 25.8˚ ±0.6 in nRHO-1;dat-1(ok157), p< =
0.0001) and dispersal (100% ±0.0 wild type at 4 hours compared to 52.7% ±2.8 nRHO-1;dat-1
(ok157), p< = 0.0001) to that of wild type animals (Fig 2B and 2C, S1 and S3 Movies). This is
consistent with previous data indicating that RHO-1 signals via multiple effectors to regulate
locomotion [16,18]. We performed rescue experiments to confirm whether the dat-1(ok157)
mutation was indeed a suppressor of nRHO-1. Two independent lines expressing a genomic
fragment containing wild type dat-1 restored the ability of increased RHO-1 signalling to
increase curvature and to prevent dispersal in nRHO-1;dat-1(ok157) animals. For example,
the curvature of rescue (line 1) was 32.5˚ ±0.1 compared to 25.8˚ ±1.9 in nRHO-1;dat-1
(ok157) and not significantly different from 33.1˚ ±0.5 in nRHO-1 (p< = 0.0001; p = 0.883).
The dispersal of rescue (line 1) at 4 hours was 5.8% ±2.7 compared to 52.7% ±2.8 in nRHO-1;
dat-1(ok157) (p< = 0.0001) and not significantly different from 7.3% ±4.2 in nRHO-1 (p> =
0.999) (Figs 1A, 1B and 2C, S5 Movie). These data indicate that the ability of RHO-1 signalling
to drive locomotion is compromised in dat-1 mutants.
dat-1 is not required for nRHO-1 increased ACh release
Constitutively active RHO-1 signalling increases the release of ACh onto body wall muscles,
which leads to a faster rate of paralysis in the presence of the acetylcholinesterase inhibitor
aldicarb (Fig 2D) [18]. We have previously assumed that the hyperactive loopy locomotion of
nRHO-1 animals is a result of increased ACh release hyper-activating muscles. Interestingly,
we found that dat-1(ok157) has no impact on the increased ACh release (hyperactive pheno-
type) observed in constitutively active RHO-1 animals, as the nRHO-1;dat-1(ok157) double
mutants remain hypersensitive to aldicarb despite being less loopy. For example, at 50 minutes,
0% ± 0.0 of wild type animals were paralysed compared to 38.3% ±7.3 of nRHO-1 (p< =
RHO-1 requires DAT-1 to control C. elegans locomotion
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0.0001), or to 43.3% ±7.3 of nRHO-1;dat-1(ok157) (p< = 0.0001) (Fig 2D). These data indi-
cate that increased ACh release at the neuromuscular junction is not solely responsible for the
increase in body curvature and dispersal phenotypes in animals with enhanced RHO-1 signal-
ling. Our data suggest additional DAT-1 dependent pathways are also required to cause the
observed changes in locomotory behaviour.
Dopamine suppresses the locomotion phenotypes of constitutively active
RHO-1 signalling
DATs negatively regulate dopamine signalling by removing dopamine from the extracellular
space, thus DAT reduces the concentration and the spread of dopamine released from the
dopaminergic neurons [21]. We predicted that dat-1 (ok157) animals, which lack DAT-1,
could potentially have increased extracellular dopamine levels and dopamine signalling. We
used two approaches to examine these possibilities. Firstly, if increased dopamine signalling is
required to suppress nRHO-1 locomotion then this suppression would be compromised in
mutants defective for dopamine synthesis such as cat-2, which encodes a tyrosine hydroxylase,
a rate-limiting enzyme required for dopamine synthesis [50]. Our results show that the cat-2
(e1112)mutation restores curvature and dispersal in nRHO-1;dat-1(ok157) animals back to
similar levels observed in nRHO-1 animals (curvature of nRHO-1;dat-1(ok157);cat-2(e1112)
34.9˚ ±0.7 compared to nRHO-1;dat-1(ok157) 25.8˚ ±0.6, p< = 0.0001 or nRHO-1 33.1˚
±0.5, p = 0.26 and dispersal at 4 hours, 22.5% ±11.4 compared to 52.7% ±2.8, p< = 0.01 or
nRHO-1 7.3% ±4.2, p = 0.53) (Figs 1A, 3A and 3B, S6 Movie). Secondly, we exposed animals
to exogenous dopamine in order to analyse the effects of increased dopamine levels on the ani-
mal’s locomotory behaviour. Exposure to dopamine significantly suppressed the increased
curvature phenotype of nRHO-1 animals from 34.4˚ ±1.2 on 0mM dopamine to 18.9˚ ±1.0
on 20mM dopamine (p< = 0.0001) (Fig 3C, S7 Movie). In other words, exogenous dopamine
exposure phenocopies the suppressive effects of the dat-1 mutation. Our data indicate that it is
an increase in extracellular dopamine in dat-1 mutants that suppresses the nRHO-1 hyperac-
tive loopy locomotion phenotype. Interestingly, 15mM exogenous dopamine paralyzes 85.0%
±7.4 of wild type animals at 50 minutes compared to only 25.8% ±6.8 of nRHO-1 animals
(p< = 0.0001) (Fig 3B). These data indicate that dopamine and nRHO-1 co-suppress each
other’s locomotion phenotypes, suggesting that these pathways antagonistically regulate
locomotion.
Dopamine acts through the DOP-1 receptor to antagonize locomotion
To date, C. elegans have four confirmed dopamine receptors (DOP-1, -2, -3 and DOP-4)
whose homology to mammalian receptors can be used to classify them into D1-like (DOP-1
and DOP-4) and D2-like (DOP-2 and DOP-3) dopamine receptors [48]. To determine which,
if any, of the four receptors mediates the suppression of hyperactive locomotion in nRHO-1;
dat-1(ok157) animals we made nRHO-1;dat-1(ok157) triple mutants with each dop mutant.
DOP-1 may play a role as the nRHO-1;dat-1(ok157);dop-1(vs101) animals had increased cur-
vature of 34.5˚ ±0.9 indistinguishable from that of nRHO-1 single mutants with 33.1˚ ±0.5
(p = 0.9374) (Fig 4A, S8 Movie). These triple mutant animals also failed to disperse with 0.6%
±0.2 at 4 hours similar to nRHO-1 with 7.3% ±4.2 (p = 0.7513) (Fig 4B). In two independent
lines transgenic animals with a fosmid containing the wild type dop-1 gene restored the sup-
pressive ability of the dat-1 mutation in nRHO-1;dat-1(ok157);dop-1(vs101) animals. These
animals have decreased curvature, for example rescue line 1 has 21.9˚ ±1.3 compared to 34.5˚
±0.9 of nRHO-1;dat-1(ok157);dop-1(vs101) triple (p< = 0.0001), and has increased dispersal
at 4 hours with 50.1% ±1.4 compared to 0.6% ±0.2 of nRHO-1;dat-1(ok157);dop-1(vs101)
RHO-1 requires DAT-1 to control C. elegans locomotion
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(P 0.001), n = 16 and 25 animals respectively. d Dopamine assay as described in materials and methods. Control strains (wild type) and nRHO-1
animals assayed on 15 mM dopamine. Genotypes are color-coded as indicated below the panel. Data presented as mean percentage of paralyzed animals
scored every 10 minutes up to 100 min ± SEM, n = 3 experiments (~30 animals per assay).
https://doi.org/10.1371/journal.pone.0204057.g003
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triple (p< = 0.0001), hence it is now similar to nRHO-1;dat-1 (ok157) mutants (Fig 4A and
4B). Mutations in dop-4 had a partial effect only on the dispersal behaviour of the nRHO-1;
dat-1(ok157);dop-4(tm1392) triple mutants (Fig 4B), however, these animals appeared to be
very sick which probably affected their locomotion (C.E. personal observation). dat-1(ok157);
dop-4(tm1392) double mutants had a dispersal phenotype similar to dat-1(ok157) (Figure b in
S2 Fig). Attempts to rescue dop-4 in the nRHO-1;dat-1(ok157);dop-4(tm1392) animals were
unsuccessful. Therefore it is unclear if DOP-4 plays a specific role in modulating the dopamine
signal that antagonizes RHO-1 signalling. Mutations in dop-2 or dop-3 had no effect on the
locomotion of nRHO-1;dat-1(ok157) animals indicating that dop-2 and dop-3 had no impact
on dat-1 suppression of nRHO-1 locomotion (Fig 4A and 4B). The control animals, each of
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Fig 4. Suppression of nRHO-1 loopy locomotion mediated via DOP-1. a Worm tracking data of body curvature of control animals (wild type, dat-1(ok157),
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https://doi.org/10.1371/journal.pone.0204057.g004
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the single dop mutant animals (in a wild type background) and their doubles with dat-1
(ok157) had wild type locomotion (Figure a in S2 Fig). Taken together, these data indicate that
mutations in dat-1 lead to increased extracellular dopamine that acts primarily via DOP-1 to
antagonize the locomotion phenotypes of nRHO-1 animals.
RHO-1 signalling regulates dat-1 expression
Our data suggest that RHO-1 and dopamine signalling antagonistically regulate locomotion,
but by what mechanism does RHO-1 signalling reduce dopamine signalling to drive locomo-
tion? DAT-1 is the major negative regulator of dopamine signalling and is required for RHO-1
mediated changes in locomotion. Our data indicates that nRHO-1 animals paralyze at a
slower rate compared to wild type animals when exposed to exogenous dopamine (Fig 3D).
We investigated whether the expression or localisation of DAT-1 was altered in nRHO-1 ani-
mals. We first created a p.dat-1::mCherry::DAT-1 translational fusion using the same genomic
fragment that we used for the dat-1 rescue (Figs 1A and 2B and 2C). mCherry signals were
detected in the four pairs of dopaminergic cells (PDE, ADE, CEPD and CEPV) in both wild
type and nRHO-1 animals suggesting the expression pattern of dat-1 was unchanged by
nRHO-1 [41,51]. In nRHO-1 animals we saw an obvious increase in the fluorescence of the
p.dat-1::mCherry::DAT-1 reporter compared to wild type animals expressing the same trans-
gene suggesting that RHO-1 increases mCherry::DAT-1 protein levels (Fig 5A). Moreover, this
increase could be induced in adult animals by expressing constitutively active RHO-1 from a
heatshock-inducible promoter (Fig 5B). In contrast, expression of a co-injected pan-neuronal
GFP reporter (p.snb-1::GFP) showed no obvious change (Fig 5A and 5B). We then tested our
observation, that dat-1 expression is increased in the presence of nRHO-1 by analysing the
mRNA level of the endogenous dat-1 gene with qPCR. dat-1 mRNA levels were almost four
times higher in nRHO-1 animals with 231.1 ±30.9 copy no/reaction compared to wild type
with 60.8 ±7.0 copy no/reaction (p< = 0.0001) (Fig 6A). dat-1 is expressed exclusively in dopa-
minergic cells, an expression pattern shared with cat-2, which is required for dopamine syn-
thesis [52]. cat-2 expression however, was not significantly altered by constitutively active
nRHO-1 (p = 0.998) (Fig 6B). We also analysed the expression levels of the 4 dopamine recep-
tors (dop-1-4), and a general neuronal gene synaptobrevin (snb-1) to exclude the possibility
that nRHO-1 was affecting global transcription. We observed no significant change in expres-
sion of dop-1-4 or snb-1 in nRHO-1 animals compared to wild type animals (Figure a-e in S3
Fig). These data indicate that RHO-1 signalling regulates dat-1 expression in particular, and
not generally the expression of components of the dopamine signalling pathway such as dop-1-
4 or cat-2. However, the transcription of other genes not tested here may also be altered in
nRHO-1 animals. The constitutively active RHO-1 construct is under the unc-17 promoter
which drives expression in cholinergic neurons [17,18], therefore nRHO-1 and dat-1’s expres-
sion pattern best fits a cell non-automonous regulation model.
Increased dat-1 expression is not a consequence of increased body
curvature, or increased ACh, or neuropeptide release
We investigated whether the increase in body curvature or the presence of DAT-1 protein itself
could cause the increase in dat-1 expression in nRHO-1 animals. Although the dat-1(ok157)
mutant fails to produce functional DAT-1 protein, the dat-1 gene retains the promoter and
transcriptional start sites. Using primers 5’ of the dat-1(ok157) deletion (Fig 6D) we detected
an even higher increase of dat-1 mRNA in nRHO-1;dat-1(ok157) animals of 480.4 ±49.5 copy
no/reaction than we did in nRHO-1 animals with 231.1 ±30.9 copy no/reaction (p< =
0.0001) (Fig 6A). As nRHO-1;dat-1(ok157) animals lack both functional DAT-1 protein and
RHO-1 requires DAT-1 to control C. elegans locomotion
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exaggerated body bends we concluded neither of these are required for nRHO-1 mediated
increases in dat-1 transcription. We have previously shown that neuronal RHO-1 negatively
regulates the diacylglycerol kinase DGK-1 [18]. dgk-1 mutations partly mimic constitutively
active RHO-1 animals as they have elevated ACh release [18,53] and increase their body cur-
vature to a level intermediate between that of wild type and nRHO-1 animals [53] and similar
to that of nRHO-1;dat-1(ok157) animals (dgk-1 22.7˚ ±0.6 compared to nRHO-1;dat-1
(ok157) 25.8˚ ±0.6, p = 0.0042) (Fig 6C). However, unlike either nRHO-1 or nRHO-1;dat-1
(ok157) animals dgk-1 mutants do not increase dat-1 expression (57.1 ±10.9 copy no/reaction
compared to wild type 60.8 ±7.0, p> = 0.9999) (Fig 6A). These data indicate that the upregula-
tion of dat-1 expression represents a new RHO-1 neuronal signalling pathway acting indepen-
dently of DGK-1, body curvature and elevated ACh release.
Fig 5. nRHO-1 increases levels of DAT-1 protein. a Representative head images of animals expressing dat-1 fused to mCherry under its endogenous promoter
(indicated in red), and a general neuronal maker, GFP expressed from the synaptobrevin promoter (indicated in green). Three pairs of dopaminergic head neurons
indicated by circles in the left panel. Wild type strain (upper pictures), nRHO-1 animals (lower pictures). Images taken at 100x magnification as described in methods.
b Representative head images of heat shock inducible RHO-1 (hsRHO-1) animals expressing dat-1 fused to mCherry under its endogenous promoter (p.dat-1::
mCherry:dat-1) indicated in red, and a general neuronal maker, GFP expressed from the synaptobrevin promoter (p.snb-1::GFP), indicated in green. Three pairs of
dopaminergic head neurons indicated by circles in the left panel. No heat shock (middle panel), after heat shock (right panel). Images taken at 100x magnification as
described in methods.
https://doi.org/10.1371/journal.pone.0204057.g005
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In addition to neurotransmitters, neuropeptides play a key role in regulating locomotion
[54–56]. We hypothesised that neuropeptides may be involved in our nRHO-1 predicted cell
non-autonomous regulation of dat-1 expression since a number of studies have shown that
neuropeptides act in a cell non-autonomous manner [57] and can regulate gene expression
[58,59]. Bhattcharya et al, showed that the neuropeptide NLP-12 modulates dopamine signal-
ling via DOP-1 and that over expression of nlp-12 (NLP-12 OE) induced a hyperactive loco-
motion phenotype [60]. NLP-12 OE animals have a similar curvature (29.7o ±1.4) to nRHO-1
animals (33.1o ±0.5, p = 0.01) compared to wild type animals (17.4o ± 0.3, p< = 0.0001) (Fig
6E). We analyzed the mRNA expression level of nlp-12 in nRHO-1 animals and observed a
significant increase in nlp-12 mRNA in nRHO-1 animals with 28,954 ± 2211 copy no/reaction
compared to wild type with 11,780 ± 354.2 copy no/reaction (p< = 0.0001) (Fig 6F). However,
dat-1 mRNA levels in the NLP-12 OE animals (86.7 ± 8.4 copy no/reaction) were not signifi-
cantly different from wild type animals with 60.8 ± 7.0 copy no/reaction (p = 0.979) (Fig 6G).
These data suggest that although nRHO-1 did significantly increase nlp-12 expression the
over-expression of nlp-12 alone does not increase dat-1 expression. Since high expression of
NLP-12 alone does not increase dat-1 expression we sought to determine whether any neuro-
peptides were involved in regulating dat-1 expression, by using mutants of two proteins
required for the priming and the exocytosis of neuropeptide loaded dense core vesicles, protein
kinase C (PKC-1) and the CAPS-1 protein UNC-31 [61,62]. We analysed dat-1 mRNA expres-
sion levels in a gain of function PCK-1 mutant (pkc-1(gf)nuIs131), which has elevated levels of
neuropeptide release and is hypersensitive to aldicarb indicating a hyperactive locomotion
phenotype [61], and also in the UNC-31 mutant (unc-31(e928)), which has reduced neuropep-
tide release and is lethargic [62,63] (Fig 6E). These mutants, however, did not show significant
changes in dat-1 mRNA expression levels (pkc-1(gf)87.4 ± 17.3 and unc-31(e928) 129.7 ± 11.1
copy no/reaction) compared to wild type animals with 60.8 ± 7.0 copy no/reaction (p> = 0.05)
(Fig 6G). We also analysed nRHO-1;unc-31(e928) double mutants to see if reduced neuropep-
tide release caused by the unc-31 mutation would decrease the increased dat-1 expression
caused by nRHO-1. We observed a slight decrease in dat-1 mRNA expression in nRHO-1;
unc-31(e928) animals with 167.4 ± 30.4 copy no/reaction when compared to nRHO-1 animals
with 231.1 ± 30.9 copy no/reaction however this decrease was not significant (p = 0.294) (Fig
6G). The limitation of using the pkc-1(gf) and the unc-31 mutants is that we are targeting gen-
eral neuropeptide release and therefore cannot distinguish between the approximately 250
individual neuropeptides that have been identified to date, many of which have opposing
effects on behaviour [64]. Therefore our data do not fully rule out the possibility that a specific
Fig 6. nRHO-1 increases transcription levels of dat-1. a and b Transcription levels of dat-1 or cat-2 in nRHO-1 single and nRHO-1;dat-1(ok157)
double mutants compared to control strains (wild type, dgk-1(sy428)) determined by quantitative PCR. Data presented as mean normalized copy number
per reaction ± SEM. Statistical comparisons were performed using one-way ANOVA with Tukey’s multiple test correction. Statistical significance
indicated as (P 0.001, n.s. = not significant), n = 6, 6, 3, 4 for a and n = 5, 5, 4 for b independent samples for each genotype respectively. c Worm
tracking data of body curvature of control animals (wild type, nRHO-1, nRHO-1;dat-1(ok157) the same data used in Figs 2B, 3A and 4A), or dgk-1
(sy428) animals. Statistical comparisons were performed using one-way ANOVA and presented as mean hip ± SEM with Tukey’s multiple test correction.
Statistical significance indicated as (P 0.001), n = 70, 32, 14, and 15 animals respectively.d Schematic of the dat-1 gene with the ok157 allele
indicated. qPCR primer set for dat-1 within first and second exon shown as arrows.e Worm tracking data of body curvature of control animals (wild type,
nRHO-1 the same data used in Figs 2B, 3A, 4A and 6C), unc-31(e928), nRHO-1;unc-31(e928) and NLP12 OE animals. Statistical comparisons were
performed using one-way ANOVA and presented as mean hip ± SEM with Tukey’s multiple test correction. Triangles indicate outliers. Statistical
significance indicated as (P 0.05, P 0.001), n = 70, 32, 12, 16 and 14 animals respectively.f Transcription levels of nlp-12 in nRHO-1 compared to
control (wild type) and NLP12 OE strains determined by quantitative PCR. Data presented as mean normalized copy number per reaction ± SEM.
Statistical comparisons were performed using one-way ANOVA with Tukey’s multiple test correction. Statistical significance indicated as (P 0.001)
n = 6, 6 and 3 independent samples for each genotype respectively. g Transcription levels of dat-1 in control (wild type, nRHO-1 the same data used in
Fig 6A) compared to pkc-1(gf), unc-31(e928), nRHO-1;unc-31(e928) and NLP12 OE strains determined by quantitative PCR. Data presented as mean
normalized copy number per reaction ± SEM. Statistical comparisons were performed using one-way ANOVA with Tukey’s multiple test correction.
Statistical significance indicated as (P 0.05, n.s. = not significant), n = 6 for all apart from n = 3 for NLP12 OE independent samples for each genotype.
https://doi.org/10.1371/journal.pone.0204057.g006
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set or single neuropeptide transmits the signal from cholinergic nRHO-1 expressing cells to
dopaminergic neurons to upregulate dat-1.
Is dat-1 upregulation required for nRHO-1 modulation of locomotion?
We next investigated whether the transcriptional upregulation of dat-1 expression was
required for nRHO-1 signalling to drive locomotion. We utilized our finding that expression
of the dopaminergic neuron specific cat-2 gene is not upregulated by nRHO-1 (Fig 6B) and
expressed dat-1 from the cat-2 promoter to generate a rescue construct in which dat-1 is no
longer regulated by RHO-1 signalling. This construct was injected into nRHO-1;dat-1(ok157)
animals in a series of increasing concentrations, with the expectation that these transgenes
would express dat-1 in proportion to the increasing copy number. Our model is that for
nRHO-1 to fully trigger changes in locomotion it must also reduce dopamine signalling. We
predicted that in nRHO-1;dat-1(ok157) animals with a transgene expressing low levels of dat-
1 mRNA there would be insufficient DAT-1 protein to inhibit dopamine signalling and that
despite the enhanced RHO-1 signalling, these animals would not display a loopy locomotion
phenotype. We observed that nRHO-1;dat-1(ok157) animals with the lowest copy number of
dat-1 still showed suppression of curvature with 26.8˚ ±0.7 compared to 25.8˚ ±0.6 for nRHO-
1;dat-1(ok157) animals (p = 0.9931) and increased dispersal at 4 hours with 75.0% ±5.5 com-
pared to 73.4% ±3.2 in nRHO-1;dat-1(ok157) animals (p = 09987) (Fig 7A and 7B, Figure a
and b in S4 Fig, S9 Movie). As we increased dat-1 expression, by increasing the plasmid con-
centration, we observed a concomitant increase in curvature and decrease in dispersal (Fig 7A
and 7B, Figure a and b in S4 Fig, S10 and S11 Movies). Animals injected with 10ng or 20ng of
p.cat-2::dat-1 increased the curvature of nRHO-1;dat-1(ok157) animals significantly from
25.8˚ ±0.3 to 31.5˚ ±0.7 and 34.3˚ ±0.9 (both p< = 0.0001). At the highest level of dat-1 expres-
sion, 20ng of p.cat-2::dat-1, the curvature of the nRHO-1;dat-1(ok157) animals equaled the
curvature of nRHO-1 animals (33.1˚ ±0.5, p = 0.9162) (Fig 7A). The effect of increasing dat-1
expression on dispersal also matched our prediction as nRHO-1;dat-1(ok157) animals con-
taining transgenes created using 10ng and 20ng of p.cat-2::dat-1 plasmid decreased dispersal
to 33.7% ±12.2 (p = 0.0019) and 21.9% ±8.8 (p = 0.0001) respectively compared to non-trans-
genic animals of the same line (Fig 7B). Moreover, the dispersal behaviour of the 20ng rescue
line was no longer significantly different from that of the hyperactive nRHO-1 animals (7.3%
±4.2, p = 0.2094) (Fig 2C).
The interpretation of these data depends on our assumption that the copy number of the
transgenes is proportional to the expression of dat-1 from these transgenes and that the 1ng of
p.cat-2::dat-1 produces a physiologically relevant amount of dat-1 protein. We measured dat-1
mRNA levels using dat-1 primers that anneal within the dat-1(ok157) deletion (Fig 7D and
7E); this ensures that we measure transcripts only from the transgene and avoid any mRNA
expression from the defective endogenous dat-1 gene. In the absence of any transgene dat-1
mRNA levels in nRHO-1;dat-1(ok157) were 7.2 ±0.3 copy no/reaction. In nRHO-1;dat-1
(ok157) animals transgenes made with 1ng, 10ng, and 20ng of p.cat-2::dat-1 plasmid the
expression of dat-1 was 43.1 ±19.2 (p = 0.99), 377.0 ±100.3 (p = 0.029), and 715.9 ±178 (p< =
0.0001) (Fig 7D), indicating that the increase in transgene concentration results in a propor-
tional increased in dat-1 expression. The expression from the 1ng of p.cat-2::dat-1 transgene
was 43.1 ±19.2 which is very similar to that of wild type dat-1 expression levels 53.5 ±15.9
(p = 0.99) (Fig 7D). Injection of 1ng of p.cat-2::dat-1 plasmid was able to rescue the previously
described swimming induced paralysis (SWIP) phenotype of the dat-1(ok157) animals [65,66]
(Fig 7Cc), indicating that these transgenes do express dat-1 mRNA at a level that produces suf-
ficient functional DAT-1 protein to reduce this phenotype. However, the transgenes in the
RHO-1 requires DAT-1 to control C. elegans locomotion
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Fig 7. Increased dat-1-levels essential for nRHO-1 mediated loopy locomotion. a Worm tracking data of body curvature of control animals
(wild type, nRHO-1 or nRHO-1;dat-1(ok157) the same data used in Figs 2B, 3A, 4A and 6C) versus nRHO-1;dat-1(ok157) expressing
increasing concentrations of an RHO-1 independent dat-1-rescuing construct (p.cat-2::dat-1). One line of each concentration is shown as
representative from two lines. Statistical comparisons were performed using one-way ANOVA and presented as mean hip ± SEM with Tukey’s
multiple test correction. Statistical significance indicated as (P< 0.001, n.s. = not significant), n = 70, 32, 15, 19, 20, and 20 animals respectively.
b Dispersal assay as described in materials and methods. Genotypes are color-coded as indicated below the panel. nRHO-1;dat-1(ok157)
expressing increasing concentrations of an RHO-1 independent dat-1-rescuing construct (p.cat-2::dat-1). One line of each dat-1-rescuing
construct concentration is shown as representative from two lines. Data presented as the mean percentage of animals on food at indicated time
points ± SEM. Statistical comparisons were performed using two-way ANOVA with Tukey’s multiple test correction. Statistical significance
indicated as (P 0.01–0.001; P< 0.001), n = 3 experiments (~200 animals per assay). c RHO-1 independent dat-1-rescue construct p.cat-2::
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SWIP assays are independent from the 1ng of p.cat-2::dat-1 transgene in the nRHO-1;dat-1
(ok157) animals and may not produce identical amounts of protein. Our data therefore suggest
that dat-1 expression levels correlate with the increased ability of RHO-1 signalling to trigger
locomotion with high curvature and a failure to disperse, however we have not fully confirmed
this. Taken together our data suggest that dat-1 expression is necessary for RHO-1 signalling
to drive locomotion and that dat-1 is a new component of a neuronal RHO-1 signalling path-
way that regulates locomotion.
Discussion
In this study we describe our finding that the C. elegans ortholog of RhoA, RHO-1, modulates
locomotory behaviour by repressing dopamine signalling through the upregulation of the
dopamine re-uptake transporter DAT-1. The most striking phenotype of expressing constitu-
tively active RHO-1 in cholinergic neurons (nRHO-1) is a switch from normal sinusoidal
locomotion to a hyperactive loopy locomotion [18]. This phenotype was quantified in two
ways: worm tracking to analyse the body curvature and dispersal assay to analyse the animal’s
ability to coordinate their locomotion towards a food source. nRHO-1 animals have increased
body curvature with much larger body bends and they cannot coordinate their locomotion
and fail to disperse, together we refer to this as loopy locomotion. The ability of nRHO-1 to
trigger loopy locomotion is strongly reduced in two separate dat-1 mutant alleles, nz99 and
ok157. We rescued this phenotype by expressing a wild type dat-1 transgene suggesting that
DAT-1 has a role in RHO-1 mediated loopy locomotion. The dat-1(ok157) also reduced RHO-
1 loopy locomotion following heat shock of hs::RHO-1 animals, indicating this is not a strain
specific effect. The reduction of loopy locomotion is not 100%, which could hint to dat-1 and
nRHO-1 acting in parallel pathways or, more likely, due to the nature of activated RHO-1 sig-
nalling being very complex and involving multiple pathways.
DATs negatively regulate dopamine signalling by removing dopamine from the extracellu-
lar space reducing the concentration and spread of dopamine released from the dopaminergic
neurons [21]. DAT mutations are predicted to increase extracellular dopamine abundance and
signalling. However, it is also possible that DAT-1 acts as a dopamine-gated depolarizing ion
channel or that chronically high levels of dopamine cause adaption such that dopamine signal-
ling could be decreased in dat-1 mutant animals [67,68]. To test if increased dopamine signal-
ling is involved in the suppression of nRHO-1 loopy locomotion we used a cat-2 mutant
background, in which dopamine synthesis is selectively reduced. The loopy locomotion phe-
notype was no longer suppressed by the dat-1 mutation in a nRHO-1;dat-1;cat-2 triple
mutant background supporting our prediction that dopamine signalling is involved. In con-
trast, if dat-1 mutants suppressed nRHO-1-mediated locomotion due to chronically
decreased dopamine signalling or if DAT-1 functions as a dopamine-activated ion channel,
the effect of the cat-2 mutation would have been minor. Furthermore, we exposed nRHO-1
single mutant animals, which have increased levels of dat-1 expression, to exogenous dopa-
mine and observed a suppression of their loopy phenotype. These data indicate that loss of
dat-1 rescues SWIP of L4 stage dat-1(ok157) animals at low injection concentrations of 1ng/μl. Data presented as mean percentage ± SEM of
animals swimming in water after 10 minutes. Statistical comparisons were performed using one-way ANOVA with Tukey’s multiple test
correction. Statistical significance indicated as (P< 0.001), n = 3 experiments (10 animals per assay). d Expression levels of dat-1 in control
(wild type) animals and non-injected control strain nRHO-1;dat-1(ok157) compared to three rescue lines with increasing plasmid concentrations
of dat-1 under cat-2 promoter (p.cat-2::dat-1) determined by quantitative PCR. Data presented as mean normalized copy number per
reaction ± SEM. Statistical comparisons were performed using one-way ANOVA with Tukey’s multiple test correction. Statistical significance
indicated as (P0.05–0.01, P 0.001, n.s. = not significant), n = 6, 4, 4, 5, and 4 independent samples for each genotype respectively. e
Schematic of the dat-1 gene with the ok157 allele indicated. qPCR primer set for dat-1 within the ok157 deletion shown as arrows.
https://doi.org/10.1371/journal.pone.0204057.g007
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dat-1 results in an increase in dopamine signalling which supresses the loopy locomotion phe-
notype of nRHO-1. We reasoned that if increased dopamine were responsible for antagoniz-
ing nRHO-1 then this would require a dopamine receptor. There are four well characterized
dopamine receptors in C. elegans, DOP-1-4 [48]. Mutations in dop-1, and partially dop-4,
reversed dat-1 suppression of the loopy locomotion in nRHO-1 animals. No change in expres-
sion was observed for any of the DOP receptors in the nRHO-1 animals. Taken together
these results suggest dat-1 suppression of nRHO-1 acts through increased dopamine signal-
ling and unlikely through the reported DAT-1 ion channel function or a change in dopamine
receptor signalling [67]. The effect of the dat-1 mutation on dopamine signalling is likely to be
complex with changes that will include both the strength of the dopamine signal received by a
cell and the number of cells that respond to dopamine as well as other changes [39]. Our data
indicate that mutations in dat-1 cause an increase in dopamine signalling via the DOP-1 recep-
tor that prevents nRHO-1 from triggering the loopy locomotion phenotype. This result is
somewhat surprising as DOP-3 receptors have been shown to be involved in the basal slowing
response upon encountering food, paralysis on exogenous dopamine and swimming induced
paralysis [39,65]. Allen et al reports that DOP-3 signalling reduces ACh-release from motor
neurons whereas DOP-1 signalling stimulates ACh-release [40]. nRHO-1;dat-1 double
mutants despite showing a clear reduction in loopy locomotion remain hypersensitive to aldi-
carb indicating no change in ACh release from motor neurons. DOP-1 receptors most likely
act in an alternative pathway to repress loopy locomotion. It has been shown recently that
RHO-1 acts to stimulate NCA channel activity to regulate locomotion [16], and that dopamine
signalling acts via DOP-3 receptors to antagonize NCA-1 channel activity [17]. The mutation
in dop-3, however, had no effect on the locomotion of nRHO-1;dat-1(ok157) animals, there-
fore the underlying mechanism is likely to be a different one.
In dat-1 mutants the absence of DAT-1 prevents nRHO-1 from triggering loopy locomo-
tion so how does nRHO-1 override the antagonistic dopamine signalling to trigger loopy
locomotion in animals with a functioning dat-1 gene? Exogenously administered dopamine
reduced loopy locomotion in nRHO-1 animals leading to paralysis, however, the nRHO-1
animals paralysed at a much slower rate in comparison to wild type animals. One interpreta-
tion of these data could be that there is reduced dopamine abundance at its site of action in the
nRHO-1 animals. We argue that this is achieved by increasing the levels of the dopamine
reuptake transporter DAT-1 in the nRHO-1 animals. We observed that nRHO-1 increased
expression of an p.dat-1::mCherry::DAT-1 fusion protein and showed that transcription from
the endogenous dat-1 gene was increased in nRHO-1 animals. Genes required for the synthe-
sis and release of dopamine from dopaminergic cells share transcriptional control elements
with dat-1 [52,69]. Of these only dat-1 and cat-2 are expressed exclusively in dopaminergic
cells and transcription of cat-2 according to our qPCR data was unaffected by nRHO-1. We
also analysed the expression levels of other dopamine pathway genes such as the dopamine
receptors dop-1-4 and a general neuronal gene expressed in dopaminergic neurons, snb-1,
none of which showed significant alteration in nRHO-1 animals. These data indicate that the
effects of nRHO-1 on dopaminergic cells did not cause a general increase in transcription,
suggesting that RHO-1 acts via DAT-1 to decrease dopamine signalling. We investigated
whether the upregulation of dat-1 was necessary for the induction of loopy locomotion, by
exploiting the observation that cat-2 mRNA level did not significantly increase in response to
nRHO-1 based on our qPCR data. We made a nRHO-1 independent dat-1 transgene using
the cat-2 promoter (p.cat-2::dat-1). nRHO-1;dat-1(ok157) animals carrying these transgenes
showed a correlation between increased expression of dat-1 through higher transgene concen-
trations and increased loopy locomotion. These data lead us to hypothesize that nRHO-1
increases the transcription of the dat-1 gene in order to trigger loopy locomotion. However,
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we recognize the caveat that the low copy number transgene, even though expressed at the
similar level to the endogenous dat-1 in wild type animals, might have been too low to rescue
the nRHO-1 phenotype as the function of an different low copy number plasmid was tested
in the SWIP assay. Additionally, the expression level of dat-1 required to rescue the SWIP phe-
notype might be different to the one required to rescue the locomotion phenotype in a nRHO-
1;dat-1(ok157) double mutant. However, active RHO-1 was not able to increase expression
levels of dat-1 when placed under the cat-2 promoter. As dat-1 mutations can only suppress
nRHO-1 in the presence of dopamine synthesis and signalling, we interpret our data as fol-
lows: RHO-1 increases dat-1 transcription resulting in increased DAT-1 protein at the cell sur-
face and consequently in a reduction of extracellular dopamine. Our data also suggest that
without a DAT-1-mediated reduction in dopamine signalling the RHO-1 signalling pathway is
severely reduced in its ability to regulate locomotion. These data indicate that we have identi-
fied an additional branch of the neuronal RHO-1 signalling pathway, which modulates loco-
motion by regulating the expression of DAT-1 and thus dopamine signalling.
The increase in dat-1 expression is not just an indirect consequence of loopy locomotion as
nRHO-1 increases expression from the non-functional dat-1(ok157) gene in non-loopy
nRHO-1;dat-1(ok157) animals. The dat-1(ok157) allele cannot produce functional DAT-1
protein due to a deletion in the dat-1 3’ end, however, the dat-1(ok157) deletion leaves the dat-
1 promoter and transcription start sites intact and we observed an increase from this faulty
dat-1 gene in the non-loopy nRHO-1;dat-1(ok157) animals. Moreover, dgk-1 mutants do not
increase dat-1 expression despite having a similar body curvature as nRHO-1;dat-1(ok157),
indicating that nRHO-1 mediated increases in dat-1 expression are not an indirect effect of
increased body curvature during loopy locomotion. How does RHO-1 regulate dat-1 expres-
sion when the cells expressing nRHO-1 and dat-1 do not overlap? Although p.unc-17 is a pro-
moter widely used to drive cholinergic neuron specific expressions of proteins [17,18] at this
moment we cannot exclude that p.unc-17::nRHO-1 may be expressed at a low level in cells
other than cholinergic neurons such as the same cell as dat-1. RhoA has been shown to regu-
late DAT-internalization in mouse midbrain slices [31], and DAT-surface availability in C. ele-
gans [43] cell autonomously linking RHO-1 to DAT function. However, our hypothesis is that
the cholinergic cells which express nRHO-1 release a RHO-1-regulated signal that acts on the
dopaminergic cells to non-autonomously regulate dat-1 expression. The signal is unlikely to
be ACh, although we cannot fully exclude the possibility that increased ACh release is neces-
sary for dat-1 expression. nRHO-1 induces the release of the neurotransmitter ACh from syn-
aptic vesicles [18] but, ACh release is also stimulated in dgk-1 mutants [18] and pkc-1(gf)
animals [61] neither of which show increased dat-1 expression. With RHO-1 playing a role in
the regulation of synaptic vesicle release [18] we investigated the possibility that RHO-1 signal-
ling could also regulate dense core vesicle release and therefore the release of neuropeptides. A
number of neuropeptides have been shown to regulate locomotion [54–56]. The neuropeptide
NLP-12 modulates dopamine signalling via DOP-1 and over-expression of nlp-12 induces a
hyperactive locomotion phenotype [60]. Although NLP-12 OE animals have a very similar
loopy locomotion as nRHO-1 animals and we show that nRHO-1 significantly increases nlp-
12 expression, dat-1 expression however was not significantly increased in the NLP-12 OE ani-
mals. These data indicate that high levels of NLP-12 do not increase dat-1 expression, but
these data do not fully exclude the involvement of nlp-12 in this RHO-1 signalling pathway.
The use of an nlp-12 loss of function mutation may shed more light on its involvement. Target-
ing general neuropeptide release via UNC-31 or PKC-1 mutants did not deliver conclusive
results on whether neuropeptides are involved in our pathway. We believe that one or more of
the over 250 distinct neuropeptides [64] would be a good candidate for the RHO-1 mediated
RHO-1 requires DAT-1 to control C. elegans locomotion
PLOS ONE | https://doi.org/10.1371/journal.pone.0204057 September 21, 2018 18 / 29
regulation of dat-1 expression and targeting individual neuropeptides represents a future task
in order to understand how RHO-1 regulates dat-1 expression to control locomotion.
In this study, we propose that changes in dat-1 expression affect the behaviour of C. elegans,
so how likely is it that changes in Dat expression can cause behavioural changes in other spe-
cies? Mice heterozygous for a Dat deletion display changes in dopamine levels intermediate
between that of wild type and full knockout mice [70]. In rats iron deficiency reduced Dat
expression and this correlated with changes in motor behaviour [71]. In humans DAT poly-
morphisms can alter DAT expression and variants associated with human mental diseases can
alter transcription over a 3 fold range, approximately the same range we observed nRHO-1 to
alter dat-1 expression [72]. The contribution of these human DAT polymorphisms to mental
disorders is being intensely studied with the clearest connection being that between changes in
DAT expression and ADHD, however, linkage between DAT alleles and a large range of men-
tal disorders or general behavioural traits are being reported [23,73]. The C. elegans RHO-1/
DAT-1 pathway increases dat-1 expression almost fourfold, from the information above such
changes in humans would alter many brain functions such as changes in mood, motivation,
movement, and cognition. If the RHO-1/DAT-1 pathway is conserved in humans then any
defects in this pathway could have effects ranging from subtle changes in behaviour to severe
mental disorders. Drugs capable of targeting such a DAT regulatory pathway could have clini-
cal applications for treatments of the wide range of mental conditions that DATs are increas-
ingly being implicated in.
Materials and methods
Strains
All strains were cultivated at 20˚C unless otherwise stated and were maintained as described
previously [74]. N2 (wild-type), CB1112 cat-2(e1112), RM2702 dat-1(ok157), LX636 dop-1
(vs101), LX702 dop-1(vs105), LX703 dop-3(vs106), FG58 dop-4(tm1392), PS2627 dgk-1(sy428),
DA509 unc-31(e928) strains were obtained from the Caenorhabditis Genetics Center (Univer-
sity of Minnesota).
BY602 dat-1(ok157);cat-2(e1112), QT1152 dat-1(ok157);dop-2(vs105), QT1153 dat-1
(ok157);dop-1(vs101), QT1154 dat-1(ok157), dop-3(vs106) a kind gift from Randy Blakely
(Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN).
NLP-12 OE nlp-12(OE) (ufIs104 (p.nlp-12::nlp-12 genomic locus)) a kind gift from Michael
Francis (Department of Neurobiology, University of Massachusetts Medical school, Worces-
ter, MA).
KP1380 pkc-1(gf)(nuIs131(p.myo::gfp;p.unc-17::pkc-1B(A160E))a kind gift from Derek Sie-
burth (Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern Cali-
fornia, LA, CA).
QT309 nzIs1 (heatshock::rho-1;p.ttx-3::GFP) nzIs29 (p.unc-17::rho-1;p.unc-122::GFP)
double mutant was made from crossing strains with the previously described transgenes [18],
QT677 nzIs1;nzIs29;nz99 (isolated from a standard EMS genetic screen), QT1125 nzIs29;dat-1
(ok157), QT1331 nzIs1;dat-1(ok157), QT1343 dat-1(ok157);dop-4(tm1392), QT1293 nzIs29;dat-
1(ok157);dop-1(vs101), QT1421 nzIs29;dat-1(ok157);dop-2(vs105), QT1335 nzIs29;dat-1
(ok157);dop-3(vs106), QT1422 nzIs29;dat-1(ok157),dop-4(tm1392), QT1441 nzIs29;dat-1
(ok157);cat-2(e1112), QT776 nzIs29;unc-31(e928).
Transgenic strains
Transgenic strains (listed as QT) were isolated by microinjection of 20 ng/ml plasmid unless
otherwise stated, together with p.acr-2::mCherry (SJN445) at 50 ng/mL (a gift of O. Hobert,
RHO-1 requires DAT-1 to control C. elegans locomotion
PLOS ONE | https://doi.org/10.1371/journal.pone.0204057 September 21, 2018 19 / 29
Columbia University, New York, NY) or p.snb-1::GFP (QT#237) at 50 ng/μl as a marker.
QT#42 heat shock hs::RHO-1 (G14V) [75]. nzIs1 contains heatshock::RHO-1;p.ttx-3::gfp,
nzIs29 contains (p.unc-17::RHO-1;p.unc-122::gfp)
QT1412 nzIs29;dat1(ok157);nzEx690[SJN617(genomic_dat-1);SJN445(p.acr-2::mCherry)]
line 2, QT1413 nzIs29;dat1(ok157);nzEx691[SJN617(genomic_dat-1);SJN445(p.acr-2::
mCherry)] line 1, QT1430 nzIs29;dat-1(ok157);dop-1(vs101);nzEx701[fosmid WRM069cF02;
QT#237(p.snb-1::GFP)] line 2, QT1435 nzIs29;dat-1(ok157);dop-1(vs101);nzEx704[fosmid
WRM069cF02;QT#237(p.snb-1::GFP)] line 1, QT1436 dat-1(ok157);nzEx705[QT#42(hs::
RHO-1(G14V));QT#237(p.snb-1::GFP);SJN717 1ng] line 2, QT1437 dat-1(ok157);nzEx706
[QT#42(hs::RHO-1(G14V));QT#237(p.snb-1::GFP);SJN717 1ng] line 1, QT1419 nzIs29;dat1
(ok157);nzEx697[SJN717(1ng)(p.cat-2::dat-1);QT#237(p.snb-1::GFP)] line 1, QT1423 nzIs29;
dat1(ok157);nzEx698[SJN717(1ng)(p.cat-2::dat-1);QT#237(p.snb-1::GFP)] line 2, QT1416
nzIs29;dat1(ok157);nzEx694[SJN717(10ng)(p.cat-2::dat-1);QT#237(p.snb-1::GFP)] line 2,
QT1417 nzIs29;dat1(ok157);nzEx695[SJN717(10ng)(p.cat-2::dat-1);QT#237(p.snb-1::GFP)]
line 1, QT1414 nzIs29;dat1(ok157);nzEx692[SJN717(20ng)(p.cat-2::dat-1);QT#237(p.snb-1::
GFP)] line 2, QT1415 nzIs29;dat1(ok157);nzEx693[SJN717(20ng)(p.cat-2::dat-1);QT#237
(p.snb-1::GFP)] line 1, QT1291 nzEx649[QT#42(1ng)(hs::RHO-1(G14V));SJN628(p.dat-1::
mCherry::dat-1;QT#237(p.snb-1::GFP)], QT1437 nzIs29;nzEx649, QT1438 nzEx649.
Plasmids
Plasmids (listed as QT# or SJN) were constructed by standard techniques, and verified by
sequencing.
SJN617 pBS dat-1 genomic fragment starting 722bp 5’ of the start ATG and 918bp 3’ of the
STOP of dat-1a was amplified by PCR with a SacI site added 5’ and a KpnI site added 3’ and
subcloned into pBluescript SK.
SJN717 p.cat-2::dat-1 genomic, an EagI site 40bp 5’ of the dat-1 start ATG was used to swap
out the promoters. An 852bp fragment of cat-2 starting 901bp 5’ and finishing 47bp 5’ of the
cat-2 start ATG was amplified with PCR with a SacI site 5’ and an EagI site 3’ and used to swap
out the SacI-EagI fragment in the dat-1 promoter of SJN617. SJN628 p.dat-1::mCherry::dat-1
A NotI site plus one base GCGGCCGCc was inserted immediately 3’ to the dat-1a start ATG
in SJN617. Into this NotI site was subcloned mCherry amplified with flanking NotI sites such
that it was in frame with dat-1 with 3 extra Alanines added at the N and C terminus by the
flanking NotI plus a base sites.
Induction of heat-shock-inducible transgenes
In all cases, expression from the heat-shock promoter was achieved using two rounds of heat
shock for 60 min at 30˚C, separated by 30 min at 20˚C, followed by recovery for 30 min at
20˚C [18].
Fluorescence microscopy
Transgenic lines were mounted on agarose pads in paralyzing agent (10 mg/ml 2,3-Butane-
dione monoxime, Sigma) and imaged on a Perkin Elmer Ultraview Vox spinning disc confocal
using a 100x oil lens. Laser images and exposures times were the same per channel and images
were obtained and processed to give maximum intensity projections of a z-series using Perkin
Elmer Volocity 6.3 software. Several control and mutants animals were observed in the same
session, and these sessions were repeated on different days.
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Aldicarb assay
Sensitivity to 1 mM aldicarb (Greyhound Chromatography) on NGM plates in the presence of
food was determined by analysing the onset of paralysis as described previously [53]. For each
experiment, 30 animals were tested, and each experiment was repeated at least in triplicate.
Dopamine locomotion assay
Assays were performed as described in [39]. For the assay, approx. 30 young adult animals
were transferred to 1.7% agar plates containing 2 mM glacial acetic acid plus or minus 15 mM
dopamine, and the number of paralysed animals were scored every 10 min for 100 min. Ani-
mals were scored as paralysed if they no longer responded to harsh touch and each experiment
was repeated at least in triplicate. For Worm tracking young adult animals were individually
transferred to dopamine plates plus or minus 20 mM dopamine, incubated for 20 min, and
then recorded on the Worm Tracker 2.0.4 system. A minimum of 16 animals were tracked per
condition.
Calculation of curvature
The mean curvature of the hip (Fig 1C) was analysed by tracking single worms using the
Worm Tracker 2.0.4 system as developed by the Schafer Lab [46]. In summary, 1-day-old
adults were transferred to low peptone tracking plates, seeded the day before with a full lawn
of OP50, and individually tracked following a 30 min acclimatization period. Animals were
tracked for 5 min and at least 12 animals were assayed over different days for each strain, with
each batch containing wild type animals. The videos were analysed using Worm Analysis Tool
Box version 3 and Matlab (Matlab script see S1 Script). For clarity one point on the worm,
mean hip (point 4), was chosen to represent alterations in curvature on subsequent strains.
This was done firstly as a means to cut down on the presented data and mean hip was specifi-
cally chosen due to potentially less interference from head movements when foraging [76]
which, could affect point 1 and 2. Point 3 could potentially be affected by the swollen vulva
phenotype of nRHO-1 animals [75] and point 5 could be affected by defecation and/or tail
swelling another phenotype of nRHO-1 animals [77].
SWIP assay
Swimming induced paralysis (SWIP) assays were performed as described in [66]. In summary
10 L4 animals were transferred to a 45ul spot of dH2O and scored for SWIP after 10 min. We
defined paralysed animals in our studies as absence of movement for at least 20 sec. The assay
was repeated at least in triplicate for each strain.
Dispersal assay
Assays were performed as described in [47]. In summary OP50 was seeded at the edge of a 10
cm NMG plate 24 hours before assay. A plate of non-starved adult animals were washed 3x in
M9 buffer (animals were allowed to settle on ice, by gravity, between each wash, as centrifuga-
tion altered dispersal of animals). Approximately 200 animals were added to the centre of the
plate and timed once the M9 buffer had been absorbed. The number of animals on food, were
scored at 20, 40, 60, 120 and 240 minutes and the total number of adults were scored at the end
of the assay. The assay was repeated at least in triplicate for each strain on different days to
minimise batch effect (Fig 1D).
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Quantitative PCR
RNA was isolated using Qiagen RNeasy mini kit following the manufacturers protocol. At least
3 independent samples were used per genotype. qPCR was performed and analyzed by qStan-
dard (www.qstandard.co.uk, 61 Wolmer Gardens, HA8 8QB Edgware UK). Primer sequences
are as follows; dat-1 set 1 forward agttggtgcctacagacgat reverse tccagcaagagaacagtggtc (Fig 6D),
dat-1 set 2 (primers that anneal within the dat-1(ok157) deletion) forward gaaatgctcaagagac-
catcgg reverse tcggagttctcatggcatactc (Fig 7E), cat-2 set forward caacaacggatccacgacat reverse
gcctatctcgtcaccaaact, nlp-12 set forward gattaccggccacttcagttc reverse cgttttccgaactgcaatgga.
Three reference genes were used based on unusually stable expression levels with relatively little
variation between adults, dauers, and L3 larvae (qStandard): Y45F10D.4 forward aagcgtcggaa-
caggaatc reverse gagtcgacgataacggaaaaa, pmp-3 (C54G10.3.1) forward tcgctgaaacaattccatga
reverse atggtcccttcacgacattg, cdc-42 (R07G3.1), forward tatgtgccgacagtcttcgacaatta, reverse
ctctatcgtatccacagaccga. The data were normalized by dividing the copy number per reaction by
the normalization factor of three reference genes from geNorm. geNorm (https://genorm.cmgg.
be/) is a popular algorithm to determine the most stable reference (housekeeping) genes from a
set of tested candidate reference genes in a given sample panel. From this, a gene expression
normalization factor can be calculated for each sample based on the geometric mean of a user-
defined number of reference genes.
Screen and whole genome sequencing
nRHO-1 animals were mutagenized using a standard C. elegans EMS protocol. 1930 haploid
genomes were screened, 116 strong suppressors of loopy locomotion (15 were unreproducible,
15 contained inactivated nzIs29 transgene) so 86 suppressor mutants were identified. The
QT677 non-loopy nRHO-1;nz99 animals were detected by eye, singled and their progeny
were shown to be non-loopy. This non-loopy phenotype was maintained following heat shock
activation of the second integrated nRHO-1 transgene, nzIs1. QT677 was chosen as a neuro-
nal-specific suppressor mutant because while it suppressed loopy locomotion driven by both
transgenes, it failed to suppress the sterility phenotype of hs::RHO-1, which is thought to have
a non-neuronal origin [75]. Whole genome sequencing (WGS) and bioinformatics of un-back-
crossed nRHO-1;nz99 animals was performed by GeneService (http://www.sourcebioscience.
com/) using Illumina 76bp paired ends sequencing that resulted in an average coverage of
greater than 10x. The WGS data of the QT677 strain (nRHO-1; nz99) was compared against
the reference nRHO-1 strain and 2809 mutations were identified, 1278 of which were induced
by EMS. These 1278 mutations led to 42 protein coding altering mutations identified by analy-
sis with MAQSeq [78] (S1 Table).
Statistical analysis
All raw data is provided as supplementary information (S1 Dataset). Statistical analysis was
performed as specified in the figure legends, using either an unpaired two-tailed t-test, one-
way ANOVA with Tukey’s multiple test correction or two-way ANOVA with Tukey’s multiple
test correction using GraphPad Prism1. P values are indicated as follows   = 0.05–0.01
  = 0.01–0.001 and   = 0.001.
Supporting information
S1 Fig. dat-1(ok157) mutation suppresses hs::RHO-1 locomotion and dat-1(ok157) versus
wild type animals body curvature. a Worm tracking data of body curvature of wild type, dat-
1(ok157), hs::RHO-1 and hs::RHO-1;dat-1(ok157) animals following heat shock. Statistical
RHO-1 requires DAT-1 to control C. elegans locomotion
PLOS ONE | https://doi.org/10.1371/journal.pone.0204057 September 21, 2018 22 / 29
comparisons were performed using one-way ANOVA and presented as mean hip ± SEM with
Tukey’s multiple test correction. Statistical significance indicated as (P 0.001, n.s. = not
significant), n = 9, 10, 5 and 11 animals respectively).
b Worm tracking data of body curvature at 5 body points within the worm (as shown in Fig
1C) comparing control animals (wild type the same data used in Fig 2B) to dat-1(ok157) ani-
mals. Statistical comparisons were performed using one-way ANOVA and presented as mean
curvature ± SEM with Tukey’s multiple test correction. Diamonds indicate outliers. Statistical
significance indicated as (n.s. = not significant), n = 70 and 14 animals respectively.
(EPS)
S2 Fig. Locomotion of control strains dop-1-4 singles and double with dat-1(ok157) muta-
tion. a Worm tracking data of body curvature of control animals (wild type, dat-1(ok157) the
same data used in Figs 2B, 3A, 4A, 6C and 7A), and four dopamine receptor single or dopa-
mine receptor dat-1(ok157) double mutants. Statistical comparisons were performed using
one-way ANOVA and presented as mean hip ± SEM with Tukey’s multiple test correction,
n = 70, 14, 15, 15, 12, 16, 13, 13, 13, and 14 animals respectively.
b Dispersal assay of control animals (dat-1(ok157) the same data used in Fig 2C), and dop-4
(tm1392) single and dat-1(ok157);dop-4(tm1392)double mutants. Genotypes are color-coded
as indicated right of the panel. Data presented as the mean percentage of animals on food at
indicated time points ± SEM, n = 3 experiments (~200 animals per assay).
(EPS)
S3 Fig. nRHO-1 does not affect the transcription levels of dop-1-4 or snb-1. a-e Transcrip-
tion levels of dop-1, dop-2, dop-3, dop-4, and snb-1 in nRHO-1 animals compared to control
strain (wild type), determined by quantitative PCR. Data presented as mean normalized copy
number per reaction ± SEM. Statistical comparisons were performed using an unpaired two-
tailed t-test. Statistical significance indicated as (n.s. = not significant), n = 3 independent sam-
ples for each genotype respectively.
(EPS)
S4 Fig. Increased dat-1-levels are essential for nRHO-1 mediated loopy locomotion. a
Worm tracking data of body curvature of control animals (wild type, nRHO-1 or nRHO-1;
dat-1(ok157) the same data used in Figs 2B, 3A, 4A, 6C and 7A) versus nRHO-1;dat-1(ok157)
expressing increasing concentrations of an RHO-1 independent dat-1-rescuing construct (p.
cat-2::dat-1). Two lines of each concentration are shown. Statistical comparisons were per-
formed using one-way ANOVA and presented as mean hip ± SEM with Tukey’s multiple test
correction. Diamonds indicate outliers. Statistical significance indicated as (P< 0.001),
n = 70, 32, 15, 19, 17, 20, 16, 20 and 19 animals respectively.
b Dispersal assay as described in materials and methods. Genotypes are color-coded as indi-
cated below the panel. nRHO-1;dat-1(ok157) expressing increasing concentrations of an
RHO-1 independent dat-1-rescuing construct (p.cat-2::dat-1). Two lines of each concentra-
tion are shown. Data presented as the mean percentage of animals on food at indicated time
points ± SEM. Statistical comparisons were performed using two-way ANOVA with Tukey’s
multiple test correction. Statistical significance indicated as (P 0.01–0.001, P < 0.001,
n.s. = not significant), n = 3 experiments (~200 animals per assay).
(EPS)
S1 Table. Predicted protein coding changes in QT677 nRHO-1;nz99. Average coverage
was greater than 10X. Bold indicates mutation in dat-1. Whole Genome sequencing and bioin-
formatics were performed by GeneService (http://www.sourcebioscience.com/).
(DOCX)
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S1 Movie. Representative locomotion of wild type animals.
(MP4)
S2 Movie. Representative locomotion of nRHO-1 animals.
(MP4)
S3 Movie. Representative locomotion of nRHO-1;dat-1(ok157) animals.
(MP4)
S4 Movie. Representative locomotion of dat-1(ok157) animals.
(M4V)
S5 Movie. Representative locomotion of nRHO-1;dat-1(ok157);genomic_dat-1 rescue ani-
mals.
(MP4)
S6 Movie. Representative locomotion of nRHO-1;dat-1(ok157);cat-2(e1112)animals.
(MP4)
S7 Movie. Representative locomotion of nRHO-1 animals exposed to 20mM dopamine.
(MP4)
S8 Movie. Representative locomotion of nRHO-1;dat-1(ok157);dop-1(vs101)animals.
(MP4)
S9 Movie. Representative locomotion of nRHO-1;dat-1(ok157) containing 1ng of p.cat-2::
dat-2 transgene line 1 animals.
(MP4)
S10 Movie. Representative locomotion of nRHO-1;dat-1(ok157) containing 10ng of p.cat-
2::dat-2 transgene line 1 animals.
(MP4)
S11 Movie. Representative locomotion of nRHO-1;dat-1(ok157) containing 20ng of p.cat-
2::dat-2 transgene line 1 animals.
(MP4)
S1 Script. Matlab script. Script used to analyse videos with Worm Analysis Tool Box version
3.
(M)
S1 Dataset. Raw data. All raw data from the study is provided as an Excel file supplementary
information.
(XLSX)
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